Real-world evidence for frequency of constipation with the use of anti-CGRP monoclonal antibodies in chronic migraine

被引：0
|
作者：
Uzun, S. [1 ,2 ]
Frejvall, U. [1 ]
Sahin, G. Ozkaya [3 ,4 ]
Sahin, G. [1 ,2 ]
机构：
[1] Skaneuro Neurol Clin, Lund, Sweden
[2] Lund Univ, Dept Clin Sci Malmo & Lund, Lund, Sweden
[3] Lund Univ, Dept Lab Med, Lund, Sweden
[4] Lund Univ, Dept Translat Med, Lund, Sweden
来源：
JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P015
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Medication Overuse Headache, Chronic Migraine and Monoclonal Antibodies Anti-CGRP: A Real-World Study
    Krymchantowski, Abouch
    Jevoux, Carla
    Krymchantowski, Ana Gabriela
    Silva-Neto, Raimundo Pereira
    CLINICAL NEUROPHARMACOLOGY, 2023, 46 (05) : 181 - 185
  • [2] The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study
    Marta Torres-Ferrús
    Victor J. Gallardo
    Alicia Alpuente
    Edoardo Caronna
    Eulalia Gine-Cipres
    Patricia Pozo-Rosich
    Journal of Neurology, 2021, 268 : 3789 - 3798
  • [3] Switching anti-CGRP monoclonal antibodies in chronic migraine: real-world observations of erenumab, fremanezumab and galcanezumab
    Talbot, Jamie
    Stuckey, Rebecca
    Wood, Natasha
    Gordon, Alexander
    Crossingham, Ginette
    Weatherby, Stuart
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2024,
  • [4] The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study
    Torres-Ferrus, Marta
    Gallardo, Victor J.
    Alpuente, Alicia
    Caronna, Edoardo
    Gine-Cipres, Eulalia
    Pozo-Rosich, Patricia
    JOURNAL OF NEUROLOGY, 2021, 268 (10) : 3789 - 3798
  • [5] Impact of anti-CGRP monoclonal antibodies on migraine attack accompanying symptoms: A real-world evidence study
    Alpuente, Alicia
    Torre-Sune, Anna
    Caronna, Edoardo
    Gine-Cipres, Eulalia
    Torres-Ferrus, Marta
    Pozo-Rosich, Patricia
    CEPHALALGIA, 2023, 43 (08)
  • [6] Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Chronic Migraine: A Real-World Retrospective Chart Review
    Salim, Amira
    Hennessy, Elise
    Sonneborn, Claire
    Hogue, Olivia
    Biswas, Sudipa
    Mays, Maryann
    Suneja, Aarushi
    Ahmed, Zubair
    Mata, Ignacio F.
    CNS DRUGS, 2024, 38 (06) : 481 - 491
  • [7] Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Chronic Migraine: A Real-World Retrospective Chart Review
    Amira Salim
    Elise Hennessy
    Claire Sonneborn
    Olivia Hogue
    Sudipa Biswas
    MaryAnn Mays
    Aarushi Suneja
    Zubair Ahmed
    Ignacio F. Mata
    CNS Drugs, 2024, 38 : 481 - 491
  • [8] Algorithm for preventing migraine through anti-CGRP monoclonal antibodies: a guide for real-world practice
    Peres, Mario
    Gama, Reinilza
    CEPHALALGIA, 2019, 39 : 271 - 271
  • [9] Safety and tolerability of anti-CGRP monoclonal antibodies: a real-world study
    Corral-Quereda, C.
    Sanchez-Casado, L.
    Diaz-de-Teran, J.
    Sastre-Real, M.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 179 - 179
  • [10] Safety and tolerability of anti-CGRP monoclonal antibodies: a real-world study
    Corral-Quereda, C.
    Sanchez-Casado, L.
    Diaz-de-Teran, J.
    Sastre-Real, M.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 120 - 121
12345